HELIOGEN, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.88 USD | -7.39% |
|
-11.74% | -6.00% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,846 | 133.7 | 11.89 | 11.24 | - | - |
| Enterprise Value (EV) 1 | 2,846 | 87.95 | 11.89 | 34.24 | 28.24 | 32.24 |
| P/E ratio | - | -0.93 x | -0.09 x | - | - | - |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 323 x | 9.72 x | - | 0.56 x | - | - |
| EV / Revenue | 323 x | 6.4 x | - | 1.71 x | - | - |
| EV / EBITDA | -88.5 x | -1.09 x | - | -0.78 x | 1.57 x | 0.54 x |
| EV / FCF | -88.8 x | -1.06 x | - | -0.25 x | -0.66 x | -0.59 x |
| FCF Yield | -1.13% | -94.2% | - | -397% | -152% | -171% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 5,239 | 5,470 | 5,946 | 5,978 | - | - |
| Reference price 2 | 543.2 | 24.44 | 2.000 | 1.880 | 1.880 | 1.880 |
| Announcement Date | 3/29/22 | 3/28/23 | 3/25/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 8.804 | 13.75 | - | 20 | - | - |
| EBITDA 1 | - | -32.14 | -80.95 | - | -44 | 18 | 60 |
| EBIT 1 | - | -48.75 | -160.2 | - | -72 | -27 | -8 |
| Operating Margin | - | -553.7% | -1,165.09% | - | -360% | - | - |
| Earnings before Tax (EBT) | - | - | -143 | - | - | - | - |
| Net income | -7.437 | -142.2 | -142 | -129.6 | - | - | - |
| Net margin | - | -1,615.07% | -1,032.65% | - | - | - | - |
| EPS | -65.80 | - | -26.25 | -22.26 | - | - | - |
| Free Cash Flow 1 | - | -32.06 | -82.84 | - | -136 | -43 | -55 |
| FCF margin | - | -364.14% | -602.42% | - | -680% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 8/9/21 | 3/29/22 | 3/28/23 | 3/25/24 | - | - | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | 5.241 | 3.539 | - | 3.1 | 4.72 | 1.937 | 1.394 | 2.273 | - |
| EBITDA | -25.45 | -16.29 | - | -19.15 | -25.75 | -17.78 | -19.28 | -18.96 | - |
| EBIT | -25.58 | -63.72 | - | -29.76 | -38 | -10.88 | -22.73 | -19.74 | - |
| Operating Margin | -488.17% | -1,800.57% | - | -959.97% | -805.11% | -561.59% | -1,630.27% | -868.68% | - |
| Earnings before Tax (EBT) | -53.52 | -59.58 | - | - | - | - | -21.68 | - | - |
| Net income 1 | -53.53 | -58.97 | - | -27.83 | -34.99 | -10.54 | -21.68 | - | -15.22 |
| Net margin | -1,021.29% | -1,666.23% | - | -897.71% | -741.23% | -544.35% | -1,555.45% | - | - |
| EPS 2 | -58.45 | -11.20 | -3.850 | -4.900 | -6.300 | -1.750 | -3.850 | - | -2.530 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 3/29/22 | 5/23/22 | 8/10/22 | 11/8/22 | 3/28/23 | 5/9/23 | 8/8/23 | 11/13/23 | 5/8/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 23 | 17 | 21 |
| Net Cash position 1 | - | - | 45.7 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.5227 x | 0.9444 x | 0.35 x |
| Free Cash Flow 1 | - | -32.1 | -82.8 | - | -136 | -43 | -55 |
| ROE (net income / shareholders' equity) | - | -157% | -83.7% | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | -86.70 | -13.60 | - | - | - | - |
| Capex 1 | - | 5.52 | 9.03 | - | 40 | 60 | 100 |
| Capex / Sales | - | 62.7% | 65.7% | - | 200% | - | - |
| Announcement Date | 8/9/21 | 3/29/22 | 3/28/23 | 3/25/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.88
Average target price
-
| 1st Jan change | Capi. | |
|---|---|---|
| -6.00% | 11.24M | |
| +57.74% | 29.09B | |
| -18.82% | 19.45B | |
| -3.21% | 17.4B | |
| -8.07% | 14.3B | |
| -8.01% | 11.26B | |
| -9.47% | 7.9B | |
| +17.76% | 7.8B | |
| +20.03% | 7.35B | |
| -27.12% | 6.86B |
- Stock Market
- Equities
- HLGN Stock
- Financials Heliogen, Inc.
